Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors☆
To access this article, please choose from the options below
☆ Supported in part by Grant CA65493 from the National Institutes of Health, Bethesda, Maryland, and by the Children’s Cancer Research Fund and Bone Marrow Transplant Fund.
PII: S0002-9343(01)00629-5
© 2001 Excerpta Medica Inc. All rights reserved.

